TFO
FOLD

Tarbox Family Office’s Amicus Therapeutics FOLD Stock Holding History

Tarbox Family Office’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-73
Closed -$1K – 1166
2021
Q1 		$1K Hold
73
– – ﹤0.01% 1020
2020
Q4 		$2K Hold
73
– – ﹤0.01% 821
2020
Q3 		$1K Hold
73
– – ﹤0.01% 956
2020
Q2 		$1K Hold
73
– – ﹤0.01% 954
2020
Q1 		$1K Buy
+73
New +$694 ﹤0.01% 856

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tarbox Family Office's FOLD Position: Q2 2021 in Review

Tarbox Family Office sold out of Amicus Therapeutics (FOLD) in Q2 2021, closing a stake of 73 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in FOLD in Q1 2020 and held it in 5 quarters. The position peaked at $2K in Q4 2020. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.

  • Tarbox Family Office reported no remaining Amicus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Tarbox Family Office sold 73 Amicus Therapeutics shares in Q2 2021, an estimated $1K.
  • Tarbox Family Office first reported a position in Amicus Therapeutics in Q1 2020 and held it in 5 quarters.
  • Tarbox Family Office's Amicus Therapeutics position peaked at $2K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.

Based on Tarbox Family Office's 13F filing for Q2 2021, filed 16 Jul 2021.